Scientific Sessions 2024  /  Evolving New Technologies in CIED Therapy: Leadless and Extravascular  /  Major Complications in Leadless Pacemakers and How to Minimize
Logo

American Heart Association

  108
  0

Final ID:

Major Complications in Leadless Pacemakers and How to Minimize

  • Gleva, Marye  ( Washington University , St. Louis , Missouri , United States )
  • Pathak, Rajeev  ( Royal Adelaide Hospital , Adelaide , South Australia , Australia )
  • Poole, Jeanne  ( UNIVERSITY WASHINGTON , Seattle , Washington , United States )
    • Author Disclosures:
    Marye Gleva: DO have relevant financial relationships ; Consultant:BIOTRONIK:Active (exists now) ; Consultant:Abbott:Active (exists now) ; Consultant:Kestra Medical Technologies:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) | Rajeev Pathak: No Answer | Jeanne Poole: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Evolving New Technologies in CIED Therapy: Leadless and Extravascular

Monday, 11/18/2024 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Can Leadless Pacemaker Expand the Role of Subcutaneous ICD?

Lloyd Michael, Pellegrini Cara, Exner Derek

When Leadless Pacemaker Needs To Be Upgrade to CRT, Abandon or Extract LP?

Glikson Michael, Bhakta Deepak, Hindricks Gerhard

More abstracts from these authors:
Primary Results from the Post Approval Study of a Next Generation Wearable Cardioverter Defibrillator System: the ACE-PAS Trial

Poole Jeanne, Gleva Marye, Branch Kelley, Birgersdotter-green Ulrika, Doshi Rahul, Mahankali Sridhar Arun Raghav, Wang Melinda, Gustavson Laura, Zulueta Shirley

2030 Call to Action to improve SCA outcomes

Poole Jeanne, Merchant Raina

You have to be authorized to contact abstract author. Please, Login
Not Available